Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Moodys
Johnson and Johnson
McKesson
McKinsey
Boehringer Ingelheim
Merck

Last Updated: October 21, 2019

DrugPatentWatch Database Preview

Litigation Details for ORTHO-MCNEIL PHARM v. BARR LABORATORIES (D.N.J. )

See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in ORTHO-MCNEIL PHARM v. BARR LABORATORIES
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for ORTHO-MCNEIL PHARM v. BARR LABORATORIES (D.N.J. )

Date Filed Document No. Description Snippet Link To Document
2009-07-22 171 including two patents: U.S. Patent No. 4,616,006 (the “’006 patent”) and U.S. Patent No. 4,628,051 …States Patent and Trademark Office (“PTO”) issued U.S. Patent No. 6,214,815 (the “’815 patent”). Ortho…Ortho owns the ’815 patent. The claims of the ’815 patent cover the combination oral contraceptive that…’815 patent. On August 20, 2003, Barr notified Ortho of its certification that the ’815 patent is invalid…of claims 1 and 4 of the ’815 patent. As affirmative defenses to patent infringement, Barr contends External link to document
2006-06-29 72 prior art patents, United States Patent No. 4,616,006 (“the ‘006 patent”) and United States Patent No. 4,628,051… infringement of United States Patent No. 6,214,815 (“the ‘815 patent”) pursuant to 35 U.S.C. § 271… his expert report that both the ‘006 patent and the ‘051 patent, when read through the eyes of the …” to create the ‘815 patent, Dr. Simon is in essence stating that the patent would have been obvious…stating that “Claims 1, 2, 3, and 4 of the ‘815 patent are invalid for External link to document
2006-10-23 77 two prior art patents: U.S. Patent No. 4,616,006 (the “’006 patent”) and U.S. Patent No. 4,628,051…States Patent and Trademark Office (“PTO”) issued U.S. Patent No. 6,214,815 (the “’815 patent”). Ortho…Ortho owns the ’815 patent. The claims of the ’815 patent cover the combination oral contraceptive that…’815 patent. On August 20, 2003, Barr notified Ortho of its certification that the ’815 patent is invalid…of claims 1 and 4 of the ’815 patent. As affirmative defenses to patent infringement, Barr contends External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Johnson and Johnson
Harvard Business School
Dow
McKinsey
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.